Ipswich Investment Management Co., Inc. Intellia Therapeutics, Inc. Transaction History

Ipswich Investment Management Co., Inc.

  • $403 Million
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 12, 2022
SELL
$58.27 - $118.99 $608,047 - $1.24 Million
-10,435 Closed
0 $0
Q4 2021

Jan 24, 2022
SELL
$100.76 - $138.36 $87,157 - $119,681
-865 Reduced 7.65%
10,435 $1.23 Million
Q3 2021

Oct 07, 2021
BUY
$132.37 - $176.78 $1.5 Million - $2 Million
11,300 New
11,300 $1.52 Million

Others Institutions Holding NTLA

# of Institutions
336
Shares Held
96.1M
Call Options Held
1.06M
Put Options Held
863K
View Full List

About Intellia Therapeutics, Inc.

NTLA Quotes by TradingView
  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $875M
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track Ipswich Investment Management Co., Inc. Portfolio

Follow Ipswich Investment Management Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ipswich Investment Management Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ipswich Investment Management Co., Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email